NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Quality of life in peruvian AIDS patients with<50 CD4 cells/mm3.

Vivar A, Garcia K; International Conference on AIDS (15th : 2004 : Bangkok, Thailand).

Int Conf AIDS. 2004 Jul 11-16; 15: abstract no. D12913.

Loayza Hospital, Lima, Peru

Background: AIDS is a well-known debilitating disease. In Peru, with poor access to HAART, emphasis is given to the provision of cotrimoxazole and isoniazid prophylaxis. Assessment of Quality of Life (QOL) is critical to determine the guidelines for palliative care. Methods Outpatients with a diagnosis os AIDS and CD4 cell count >120 cells/mm3 were asked to participate. Personal interviews were done in patients who gave their consent, data was collected in a structured questionnaire. The Medical Outcome Study (MOS)-HIV Health survey was used to assess global QOL. Additionally, two visual scales from EuroQuality of Life Group (ED-5D) were used to assess self perception of health and future expectations. The Karnofsky Performance Score was used to assess functional capacity. Finally, we asked for the presence of symptoms by the time of the interview. Results: A total of 51 AIDS patients were enrolled ( 64.7% females, 35.3% males). At the time of the interview it had been a mean of 19.3 months sincethe the HIV was diagnosed and 9.7 months since becoming full-blown AIDS. Mean CD4 cell count was 75.4 cells/mm3 (<30 to 120). Current chemoprophylaxis were 82.4% for cotrimoxazole and 66.7% for Isoniazid. Eightytwo percent of AIDS patients were living with their parents. Seventy two percent were no longer working. Limitations for daily living activities were present in 74.5%. Social limitation was found in 78.4%. Cognitive impairment was found in 55% of cases. Affective disorders found: Anxiety 98% and Depression 80%. Mean number of symptoms during the interview were 6.5, the most common were: Anorexia (43.2%), Fatigue (76.5%), Pain (61%)Wasting (52.9%), Dyspnea (58.8%), Insomnia (52.9%), Nausea/vomiting (49%), Pruritus (49%). Paresthesias (49%). Self'perception of health was considered as Bad (25.5%), Not Good (45.1%) and Good (29.4%). A Karnofsky score<70 was found in 56.9% of patients. Conclusions: AIDS is imposing a significant impairment of QOL, in cognitive, social. emotional and physical activities. In the absence of HAART, palliative care is encouraged.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Activities of Daily Living
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Female
  • HIV Infections
  • HIV Seropositivity
  • Health Surveys
  • Humans
  • Interviews as Topic
  • Karnofsky Performance Status
  • Life
  • Male
  • Palliative Care
  • Peru
  • Quality of Life
  • Questionnaires
  • rehabilitation
Other ID:
  • GWAIDS0034196
UI: 102278412

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov